Cite
HARVARD Citation
Goyal, A. et al. (2019). Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotin. Journal of cutaneous pathology. pp. 823-829. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Goyal, A. et al. (2019). Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotin. Journal of cutaneous pathology. pp. 823-829. [Online].